Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells
Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells
复制标题
DOI:
10.1073/pnas.1917125117
复制
发表时间:
2020-05-19
影响因子:
11.1
通讯作者:
Jonas, Steven J.
中科院分区:
文献类型:
--
作者:
Belling, Jason N.;Heidenreich, Liv K.;Jonas, Steven J.
Advances in gene editing are leading to new medical interventions where patients' own cells are used for stem cell therapies and immunotherapies. One of the key limitations to translating these treatments to the clinic is the need for scalable technologies for engineering cells efficiently and safely. Toward this goal, microfluidic-strategies to induce membrane pores and permeability have emerged as promising techniques to deliver biomolecular cargo into cells. As these technologies continue to mature, there is a need to achieve efficient, safe, nontoxic, fast, and economical processing of clinically relevant cell types. We demonstrate an acoustofluidic sonoporation method to deliver plasmids to immortalized and primary human cell types, based on pore formation and permeabilization of cell membranes with acoustic waves. This acoustofluidic-mediated approach achieves fast and efficient intracellular delivery of an enhanced green fluorescent protein-expressing plasmid to cells at a scalable throughput of 200,000 cells/min in a single channel. Analyses of intracellular delivery and nuclear membrane rupture revealed mechanisms underlying acoustofluidic delivery and successful gene expression. Our studies show that acoustofluidic technologies are promising platforms for gene delivery and a useful tool for investigating membrane repair.